Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden
· Delayed Price · Currency is SEK 16.50
-0.08 (-0.48%)
At close: Dec 3, 2025
Cinclus Pharma Holding AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 540.22 | 566.72 | 87.97 | 173.55 | 138.2 | 208.5 | Upgrade
|
| Cash & Short-Term Investments | 540.22 | 566.72 | 87.97 | 173.55 | 138.2 | 208.5 | Upgrade
|
| Cash Growth | -16.15% | 544.20% | -49.31% | 25.57% | -33.72% | 1449.96% | Upgrade
|
| Accounts Receivable | 0.62 | 4.58 | - | - | - | - | Upgrade
|
| Other Receivables | 2.72 | 2.93 | 3.98 | 10.23 | 1.38 | 0.17 | Upgrade
|
| Receivables | 3.34 | 7.51 | 3.98 | 10.23 | 1.38 | 0.17 | Upgrade
|
| Prepaid Expenses | 33.91 | 1.23 | 2.14 | 1.11 | 0.39 | 0.11 | Upgrade
|
| Other Current Assets | - | 25.02 | - | - | 5.38 | 3.6 | Upgrade
|
| Total Current Assets | 577.46 | 600.47 | 94.09 | 184.88 | 145.36 | 212.39 | Upgrade
|
| Property, Plant & Equipment | 10.14 | 0.54 | 0.32 | 0.89 | 1.82 | 0.02 | Upgrade
|
| Other Long-Term Assets | 0.3 | 0 | 0 | 0 | 0 | 0.07 | Upgrade
|
| Total Assets | 587.9 | 601.01 | 94.41 | 185.77 | 147.18 | 212.47 | Upgrade
|
| Accounts Payable | 20.97 | 18.93 | 16.45 | 16.95 | 9.19 | 5.42 | Upgrade
|
| Accrued Expenses | 33.31 | 16.9 | 6.83 | 20.47 | 7.51 | 0.64 | Upgrade
|
| Short-Term Debt | - | - | 131.01 | - | - | - | Upgrade
|
| Current Portion of Leases | 3.05 | 0.11 | 0.02 | 0.54 | 0.85 | - | Upgrade
|
| Current Income Taxes Payable | 0.16 | 7.45 | 7.22 | 5.4 | - | - | Upgrade
|
| Other Current Liabilities | 3.04 | 2.11 | 2.9 | 2.74 | 1.92 | 0.43 | Upgrade
|
| Total Current Liabilities | 95.03 | 45.49 | 164.42 | 46.1 | 19.47 | 6.49 | Upgrade
|
| Long-Term Leases | 5.6 | 0.19 | - | - | 0.61 | - | Upgrade
|
| Other Long-Term Liabilities | -0 | - | 6.79 | 12.8 | - | - | Upgrade
|
| Total Liabilities | 157.99 | 45.68 | 171.21 | 58.9 | 20.08 | 6.49 | Upgrade
|
| Common Stock | 0.92 | 0.92 | 0.51 | 0.51 | 0.26 | 0.26 | Upgrade
|
| Additional Paid-In Capital | 1,298 | 1,298 | 503.52 | 503.69 | 276.74 | 271.72 | Upgrade
|
| Retained Earnings | -892.4 | -772 | -606.84 | -394.16 | -145.08 | -68.82 | Upgrade
|
| Comprehensive Income & Other | 23.66 | 28.67 | 26 | 16.84 | -4.82 | 2.82 | Upgrade
|
| Shareholders' Equity | 429.91 | 555.33 | -76.8 | 126.87 | 127.1 | 205.99 | Upgrade
|
| Total Liabilities & Equity | 587.9 | 601.01 | 94.41 | 185.77 | 147.18 | 212.47 | Upgrade
|
| Total Debt | 8.65 | 0.3 | 131.03 | 0.54 | 1.46 | - | Upgrade
|
| Net Cash (Debt) | 531.57 | 566.42 | -43.06 | 173 | 136.75 | 208.5 | Upgrade
|
| Net Cash Growth | -17.44% | - | - | 26.51% | -34.41% | 1449.96% | Upgrade
|
| Net Cash Per Share | 11.42 | 15.29 | -1.64 | 7.51 | 6.48 | 841.82 | Upgrade
|
| Filing Date Shares Outstanding | 46.54 | 46.54 | 26.23 | 0.33 | 0.26 | 0.25 | Upgrade
|
| Total Common Shares Outstanding | 46.54 | 46.54 | 26.23 | 0.33 | 0.26 | 0.25 | Upgrade
|
| Working Capital | 482.44 | 554.97 | -70.33 | 138.78 | 125.89 | 205.9 | Upgrade
|
| Book Value Per Share | 9.24 | 11.93 | -2.93 | 387.00 | 481.30 | 831.67 | Upgrade
|
| Tangible Book Value | 429.91 | 555.33 | -76.8 | 126.87 | 127.1 | 205.99 | Upgrade
|
| Tangible Book Value Per Share | 9.24 | 11.93 | -2.93 | 387.00 | 481.30 | 831.67 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.